Reimagine Care announced that it has partnered with The Center for Cancer & Blood Disorders (CCBD), one of the country’s most respected cancer centers, to offer its home-based supportive care and symptom management program to patients in the Dallas-Fort Worth area.
Thousands of CCBD patients will have access to on-demand support from experienced oncology nurses and advanced practitioners via text, phone, and video, along with in-home care when appropriate. This proactive approach is designed to reduce patients’ symptom burden, improve the patient and caregiver experience, and eliminate unnecessary ED visits and avoidable hospital admissions that occur today. The Reimagine Care program also alleviates much of the triage and symptom management demands on CCBD clinicians, improving provider well-being and increasing clinical capacity.
“Partnering with Reimagine Care provides our patients the ability to receive robust clinical support in the comfort of their homes as they navigate their cancer journey, which we believe will make a significant impact on outcomes,” said CCBD CEO Barry Russo. “As a practice that is consistently on the forefront of innovation within oncology, this home-centric model enables us to go another step further in making the lives of our patients and their caregivers better, while also improving the experience of our physicians and nurses.”
The partnership is happening in the context of an increased focus within the oncology industry on making high-quality cancer care more accessible and affordable. Organizations like the Centers for Medicare & Medicaid Services, which launches its Enhancing Oncology Model in July of 2023, have created programs aimed at delivering more holistic, patient-centric cancer care, with an increased focus on early identification and management of symptoms, reduced unnecessary hospital utilization, and improved health equity.
“It is an honor to be working with one of the most forward thinking, well-respected independent oncology practices in the nation,” said Reimagine Care CEO and Co-Founder Dr. Aaron Gerber. “We are looking forward to collaborating with CCBD clinicians to improve quality of care through more proactive symptom management, while providing a highly differentiated experience for their patients.”
Read the original press release here.
See additional coverage in: